These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dietary Care for ADPKD Patients: Current Status and Future Directions. Carriazo S; Perez-Gomez MV; Cordido A; García-González MA; Sanz AB; Ortiz A; Sanchez-Niño MD Nutrients; 2019 Jul; 11(7):. PubMed ID: 31336917 [TBL] [Abstract][Full Text] [Related]
10. Intermittent fasting interventions for the treatment of overweight and obesity in adults aged 18 years and over: a systematic review protocol. Jane L; Atkinson G; Jaime V; Hamilton S; Waller G; Harrison S JBI Database System Rev Implement Rep; 2015 Oct; 13(10):60-8. PubMed ID: 26571283 [TBL] [Abstract][Full Text] [Related]
11. Is autosomal dominant polycystic kidney disease an early sweet disease? Dachy A; Decuypere JP; Vennekens R; Jouret F; Mekahli D Pediatr Nephrol; 2022 Sep; 37(9):1945-1955. PubMed ID: 34988697 [TBL] [Abstract][Full Text] [Related]
12. Nutritional therapy in autosomal dominant polycystic kidney disease. Di Iorio BR; Cupisti A; D'Alessandro C; Bellasi A; Barbera V; Di Lullo L J Nephrol; 2018 Oct; 31(5):635-643. PubMed ID: 29344814 [TBL] [Abstract][Full Text] [Related]
13. Can ketogenic dietary interventions slow disease progression in ADPKD: what we know and what we don't. Ong ACM; Torra R Clin Kidney J; 2022 Jun; 15(6):1034-1036. PubMed ID: 35664267 [TBL] [Abstract][Full Text] [Related]
14. Weight loss and cystic disease progression in autosomal dominant polycystic kidney disease. Hopp K; Catenacci VA; Dwivedi N; Kline TL; Wang W; You Z; Nguyen DT; Bing K; Poudyal B; Johnson GC; Jackman MR; Miller M; Steele CN; Serkova NJ; MacLean PS; Nemenoff RA; Gitomer B; Chonchol M; Nowak KL iScience; 2022 Jan; 25(1):103697. PubMed ID: 35059607 [TBL] [Abstract][Full Text] [Related]
15. Emerging non-pharmacological interventions in ADPKD: an update on dietary advices for clinical practice. Meijer E; Gansevoort RT Curr Opin Nephrol Hypertens; 2021 Sep; 30(5):482-492. PubMed ID: 34261861 [TBL] [Abstract][Full Text] [Related]
16. The Clinical Manifestation and Management of Autosomal Dominant Polycystic Kidney Disease in China. Xue C; Zhou CC; Wu M; Mei CL Kidney Dis (Basel); 2016 Oct; 2(3):111-119. PubMed ID: 27921038 [TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study. Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426 [TBL] [Abstract][Full Text] [Related]
18. Diet and Physical Activity in Adult Dominant Polycystic Kidney Disease: A Review of the Literature. Capelli I; Lerario S; Aiello V; Provenzano M; Di Costanzo R; Squadrani A; Vella A; Vicennati V; Poli C; La Manna G; Baraldi O Nutrients; 2023 Jun; 15(11):. PubMed ID: 37299584 [TBL] [Abstract][Full Text] [Related]
19. Trigger Warning: How Modern Diet, Lifestyle, and Environment Pull the Trigger on Autosomal Dominant Polycystic Kidney Disease Progression. Messing M; Torres JA; Holznecht N; Weimbs T Nutrients; 2024 Sep; 16(19):. PubMed ID: 39408247 [TBL] [Abstract][Full Text] [Related]
20. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic kidney disease. Torres VE; Abebe KZ; Schrier RW; Perrone RD; Chapman AB; Yu AS; Braun WE; Steinman TI; Brosnahan G; Hogan MC; Rahbari FF; Grantham JJ; Bae KT; Moore CG; Flessner MF Kidney Int; 2017 Feb; 91(2):493-500. PubMed ID: 27993381 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]